During the past decade, Waehringer Guertel conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Waehringer Guertel" are "Bronchiolitis Obliterans" (2 trials), "Bronchiolitis Obliterans Syndrome" (1 trials), "Chronic Lung Allograft Dysfunction" (1 trials), "Chronic Rejection of Lung Transplant" (1 trials) and "Lung Transplant Failure and Rejection" (1 trials). Many other conditions were trialed in "Waehringer Guertel" in a lesser frequency.

Most popular intervention types in "Waehringer Guertel" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Liposomal Cyclosporine A" (1 trials), "Liposomal Cyclosporine A 10 mg" (1 trials), "Liposomal Cyclosporine A 5 mg" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Waehringer Guertel" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Waehringer Guertel". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Waehringer Guertel, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Waehringer Guertel, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".